ATE85081T1 - Analoge des gewebespezifischen plasminogenaktivators. - Google Patents

Analoge des gewebespezifischen plasminogenaktivators.

Info

Publication number
ATE85081T1
ATE85081T1 AT86309704T AT86309704T ATE85081T1 AT E85081 T1 ATE85081 T1 AT E85081T1 AT 86309704 T AT86309704 T AT 86309704T AT 86309704 T AT86309704 T AT 86309704T AT E85081 T1 ATE85081 T1 AT E85081T1
Authority
AT
Austria
Prior art keywords
analogs
tpa
plasminogen activator
tissue specific
specific plasminogen
Prior art date
Application number
AT86309704T
Other languages
English (en)
Inventor
Keith R Marotti
Edward F Rehberg
Nicole Y Theriault
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE85081T1 publication Critical patent/ATE85081T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86309704T 1985-12-20 1986-12-12 Analoge des gewebespezifischen plasminogenaktivators. ATE85081T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81160785A 1985-12-20 1985-12-20
US90948286A 1986-09-19 1986-09-19
EP86309704A EP0231624B1 (de) 1985-12-20 1986-12-12 Analoge des gewebespezifischen Plasminogenaktivators

Publications (1)

Publication Number Publication Date
ATE85081T1 true ATE85081T1 (de) 1993-02-15

Family

ID=27123502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86309704T ATE85081T1 (de) 1985-12-20 1986-12-12 Analoge des gewebespezifischen plasminogenaktivators.

Country Status (12)

Country Link
EP (2) EP0231624B1 (de)
JP (1) JPH0659223B2 (de)
KR (2) KR950000303B1 (de)
AT (1) ATE85081T1 (de)
AU (1) AU600463B2 (de)
DE (1) DE3687651T2 (de)
DK (1) DK431887A (de)
ES (1) ES2053449T3 (de)
FI (1) FI97809C (de)
GR (1) GR3007280T3 (de)
NO (1) NO176921C (de)
WO (1) WO1987003906A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
DE3682891D1 (de) * 1986-02-17 1992-01-23 Stichting Centraal Lab Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
EP0263172B1 (de) * 1986-03-28 1993-06-23 Creative Biomolecules, Inc. Proteinanaloge des gewebs-plasminogenaktivators
US5047241A (en) * 1986-07-11 1991-09-10 American Home Products Corporation Tris-Kringle plasminogen activator with novel K2 insert
US5242819A (en) * 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
US5580559A (en) * 1986-12-05 1996-12-03 Ciba-Geigy Corporation Hybrid plasminogen activator
AU1295088A (en) * 1987-01-30 1988-08-24 American Home Products Corporation Des-epidermal growth factor plasminogen activators
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US5037752A (en) * 1987-10-09 1991-08-06 Monsanto Company Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
US5100666A (en) * 1987-10-09 1992-03-31 Monsanto Company Modified tissue plasminogen activator K2K2SP
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
EP0311589B1 (de) * 1987-10-09 1994-03-23 Monsanto Company Modifizierter Gewebeplasminogenaktivator
KR970005046B1 (ko) * 1987-10-29 1997-04-11 야마노우찌 세이야꾸 가부시끼가이샤 개량형 조직 플라스미노겐 활성화 인자
US5648254A (en) * 1988-01-15 1997-07-15 Zymogenetics, Inc. Co-expression in eukaryotic cells
WO1989007146A1 (en) * 1988-02-05 1989-08-10 Integrated Genetics, Inc. Rearranged tissue plasminogen activators and method for producing same
AU619803B2 (en) * 1988-02-05 1992-02-06 Genzyme Corporation Rearranged tissue plasminogen activators and method for producing same
AU3064989A (en) * 1988-02-05 1989-08-25 Genzyme Corporation Modified gene sequences encoding modified tpa and products therefrom
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
DE3823805A1 (de) * 1988-07-14 1990-01-18 Basf Ag Neue polypeptide, ihre herstellung und verwendung
DE3825253A1 (de) * 1988-07-25 1990-02-01 Boehringer Mannheim Gmbh T-pa-derivat und seine herstellung
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
DE3836200A1 (de) * 1988-10-24 1990-04-26 Boehringer Mannheim Gmbh Domaenenduplikations-muteine des gewebsplasminogen-aktivators (t-pa)
EP0440709B1 (de) * 1988-10-27 1995-05-24 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Trombolytischer wirkstoff mit modifikation der domäne der kringle
CA2007364A1 (en) * 1989-01-17 1990-07-17 David J. Livingston Gene sequences encoding modified residues situated in the protease domain of tpa
DE3927865A1 (de) * 1989-08-23 1991-02-28 Boehringer Mannheim Gmbh T-pa-mutante gk1l
JP3559559B2 (ja) * 1992-06-03 2004-09-02 ジェネンテク，インコーポレイテッド 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体
IL104355A (en) * 1993-01-10 2006-08-20 Yeda Res & Dev Tnf receptor promoter
US5795975A (en) * 1993-01-10 1998-08-18 Yeda Research And Development Co. Ltd. TNF receptor promoter
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
ZA837173B (en) 1982-11-08 1984-05-30 Univ Case Western Reserve Genomic bovine growth hormone
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
DK149786A (da) * 1985-04-04 1986-10-04 Beecham Group Plc Proteolytisk enzym
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product

Also Published As

Publication number Publication date
GR3007280T3 (de) 1993-07-30
DK431887D0 (da) 1987-08-19
KR950000303B1 (ko) 1995-01-13
ES2053449T3 (es) 1994-08-01
JPH0659223B2 (ja) 1994-08-10
FI882922L (fi) 1988-06-17
EP0231624A1 (de) 1987-08-12
FI882922A0 (fi) 1988-06-17
FI97809C (fi) 1997-02-25
KR880700856A (ko) 1988-04-12
WO1987003906A1 (en) 1987-07-02
NO873517D0 (no) 1987-08-20
FI97809B (fi) 1996-11-15
NO176921B (no) 1995-03-13
DE3687651D1 (de) 1993-03-11
NO176921C (no) 1995-06-21
JPH05344892A (ja) 1993-12-27
EP0231624B1 (de) 1993-01-27
NO873517L (no) 1987-08-20
EP0289508A1 (de) 1988-11-09
DE3687651T2 (de) 1993-06-24
AU600463B2 (en) 1990-08-16
DK431887A (da) 1987-08-19
AU6770187A (en) 1987-07-15

Similar Documents

Publication Publication Date Title
DE3687651D1 (de) Analoge des gewebespezifischen plasminogenaktivators.
AU568067B2 (en) Oligonucleotide therapeutic agent and methods of making same
ATE239789T1 (de) Chimäre prokoagulierende proteine
DK306386A (da) Fibronectin og polypeptidsekvenser omfattende de collagenbindende og/eller fibrinbindende dele deraf, cdna-sekvenser, som koder herfor, vektorer indeholdende cdna-sekvenserne mikroorganismer transformeret dermed og fremgangsmaade til rensning af stoffer
KR850007275A (ko) 기능성 인체인자 ⅷ의 제조방법
ATE323169T1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
DE3682891D1 (de) Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
ATE114169T1 (de) Morphogenetisches knochenprotein.
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
AU1094892A (en) Improved activation of recombinant proteins
NZ234453A (en) Recombinant dna encoding urate oxidase, and vector, host, protein and pharmaceutical compositions associated therewith
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
HUT68379A (en) Method for modifying the cell, tissue or host tropism of a recombinant microorganism obtained this way and use thereof in medicine and veterinary medicine
EP0804613A4 (de) Tumorsupressorgene, durch sie kodierte proteine und die verwendung besagter gene und proteine
NO179874C (no) Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekvens som koder for t-PA-analogen, samt ekspresjonsvektor omfattende DNA-sekvensen og vertcelle omfattende denne
NZ242124A (en) Dna encoding an enzyme having arabinan-degrading activity
NO971139L (no) Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler
NZ222434A (en) Tissue factor protein lacking its naturally associated phospholipid
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
ZA898479B (en) Injury-stimulated dna sequence from solanum tuberosum,and use thereof
DK383488D0 (da) Humant papillomavirus type 41, dets dna og deraf kodede proteiner
AU630099B2 (en) Non-reverting rna viruses
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
DE69532109D1 (de) Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors